Data deals: Week 14, 2026 (30 Mar to 5 Apr)
3 deals announced this week. ✓ Reviewed: read and analysed by Gianluca. Others are short summaries of the public record.
- 2026-04-02 · TriNetX · Regeneron Pharmaceuticals
TriNetX licenses access to data on about 300 million patients to Regeneron for drug discovery✓
TriNetX licenses Regeneron access to de-identified health data on about 300 million people, with the exclusive opportunity to connect Regeneron's own genomic and proteomic cohorts to TriNetX's phenotypic network. Regeneron will also invest up to $200 million in TriNetX.
- 2026-04-01 (reported) · Anthropic · Coefficient Bio · Dimension
Anthropic's $400M acquisition of Coefficient Bio for domain-specific biotech data underscores substrate dimensions✓
Anthropic announced the acquisition of Coefficient Bio in April 2026 for approximately $400M in Anthropic stock, folding its 10-person team and proprietary biotech data into Claude for Life Sciences. Founded in August 2025 by ex-Genentech researchers Samuel Stanton and Nathan Frey and half-owned by Dimension, Coefficient sold data with regulated provenance that Claude could not scrape.
- 2026-03-30 · Inovisco · Edeka · Digooh · Emsu
Retail Media Alliance goes live, uniting Digooh, Emsu and Viewento screens in Edeka stores under Inovisco
On 30 March 2026, the Retail Media Alliance went live as a Germany-wide in-store network combining screens from Digooh, Emsu and Viewento (Verve Retail Media) in Edeka stores, with Inovisco Mobile Media as the central marketing partner. Existing Inovisco clients gain immediate access to the expanded inventory.